Kirsten Wilcox
Operations Director – Brisbane
Kirsten Wilcox (BSc) has 12 years of experience in regulatory bioanalysis and joined Agilex Biolabs in 2020. When she joined the LCMS group, she was responsible for ensuring the smooth operation of the analytical teams throughout the drug development process, from validation to sample analysis. Her goal was to ensure that work was performed to meet regulatory standards and delivered promptly to support the progression of drugs along their clinical pathways. In her current role, she is dedicated to advancing toxicology and immunobiology in Australia. She aims to collaborate with leaders in these scientific fields to facilitate the successful launch of promising drugs into clinical settings and to maximize the insights gained from clinical trials, ultimately enhancing patient outcomes.
